KEY FEATURES
Full Name | CCAAT/Enhancer Binding Protein Alpha |
---|---|
Synonym | CEBP-A |
Assay Type | Sandwich |
Reactivity | Human |
Range | 0.15-10ng/mL |
Sensitivity | 0.07ng/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human CEBPa in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CEBPa. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CEBPa and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CEBPa, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CEBPa. You can calculate the concentration of Human CEBPa in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CEBPa ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 0.5 | 1.24 | 3.37 | 0.51 | 1.13 | 3.49 |
Standard deviation | 0.03 | 0.07 | 0.13 | 0.03 | 0.05 | 0.14 |
CV(%) | 6.64 | 5.95 | 3.89 | 5.35 | 4.36 | 4.02 |
RECOVERY
The recovery of Human CEBPa spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 88-103 | 95 |
EDTA plasma (n=8) | 91-103 | 96 |
Cell culture media (n=8) | 93-104 | 99 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CEBPa in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Pathways associated with ELISA Kit
Acute Myeloid Leukemia Pathway | Acute Myeloid Leukemia Pathway |
Adipogenesis Pathway | Adipogenesis Pathway |
C-MYB Transcription Factor Network Pathway | C-MYB Transcription Factor Network Pathway |
Developmental Biology Pathway | Developmental Biology Pathway |
E2F Transcription Factor Network Pathway | E2F Transcription Factor Network Pathway |
EGFR1 Signaling Pathway | EGFR1 Signaling Pathway |
FOXA2 And FOXA3 Transcription Factor Networks Pathway | FOXA2 And FOXA3 Transcription Factor Networks Pathway |
Non-alcoholic Fatty Liver Disease (NAFLD) Pathway | Non-alcoholic Fatty Liver Disease (NAFLD) Pathway |
Diseases associated with CEBPa ELISA Kit
Leukemia, Myeloid, Acute | publications with CEBPa and Leukemia, Myeloid, Acute |
Liver Diseases | publications with CEBPa and Liver Diseases |
Insulin Resistance | publications with CEBPa and Insulin Resistance |
Inflammation | publications with CEBPa and Inflammation |
Necrosis | publications with CEBPa and Necrosis |
Fatty Liver | publications with CEBPa and Fatty Liver |
Disease Models, Animal | publications with CEBPa and Disease Models, Animal |
Liver Neoplasms | publications with CEBPa and Liver Neoplasms |
Cell Transformation, Neoplastic | publications with CEBPa and Cell Transformation, Neoplastic |
Carcinoma, Hepatocellular | publications with CEBPa and Carcinoma, Hepatocellular |
Organs/Tissues associated with CEBPa ELISA Kit
Blood | publications with CEBPa and Blood |
Liver | publications with CEBPa and Liver |
Adipose Tissue | publications with CEBPa and Adipose Tissue |
Connective Tissue | publications with CEBPa and Connective Tissue |
Bone | publications with CEBPa and Bone |
Bone Marrow | publications with CEBPa and Bone Marrow |
Lung | publications with CEBPa and Lung |
Brain | publications with CEBPa and Brain |
Embryonic Tissue | publications with CEBPa and Embryonic Tissue |
Kidney | publications with CEBPa and Kidney |